thiazolyl blue has been researched along with Bright Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryl, E; Bułło, B; Debska-Slizień, A; Myśliwska, J; Myśliwski, A; Rachoń, D; Rutkowski, B; Trzonkowski, P; Zdrojewski, Z | 1 |
1 other study(ies) available for thiazolyl blue and Bright Disease
Article | Year |
---|---|
Recombinant human erythropoietin stimulates production of interleukin 2 by whole blood cell cultures of hemodialysis patients.
Topics: Adjuvants, Immunologic; Adult; Blood Cells; Cells, Cultured; Chromogenic Compounds; Chronic Disease; Colorimetry; Coloring Agents; Erythropoietin; Female; Glomerulonephritis; Humans; Interleukin-2; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Phytohemagglutinins; Recombinant Proteins; Renal Dialysis; T-Lymphocytes; Tetrazolium Salts; Thiazoles | 1999 |